BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12697265)

  • 1. Role of inherited defects decreasing Fas function in autoimmunity.
    Dianzani U; Chiocchetti A; Ramenghi U
    Life Sci; 2003 May; 72(25):2803-24. PubMed ID: 12697265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
    Ramenghi U; Bonissoni S; Migliaretti G; DeFranco S; Bottarel F; Gambaruto C; DiFranco D; Priori R; Conti F; Dianzani I; Valesini G; Merletti F; Dianzani U
    Blood; 2000 May; 95(10):3176-82. PubMed ID: 10807785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
    Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.
    Clementi R; Chiocchetti A; Cappellano G; Cerutti E; Ferretti M; Orilieri E; Dianzani I; Ferrarini M; Bregni M; Danesino C; Bozzi V; Putti MC; Cerutti F; Cometa A; Locatelli F; Maccario R; Ramenghi U; Dianzani U
    Blood; 2006 Nov; 108(9):3079-84. PubMed ID: 16720836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
    Fleisher TA; Straus SE; Bleesing JJ
    Curr Allergy Asthma Rep; 2001 Nov; 1(6):534-40. PubMed ID: 11895618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
    Rieux-Laucat F; Magérus-Chatinet A; Neven B
    J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases.
    DeFranco S; Bonissoni S; Cerutti F; Bona G; Bottarel F; Cadario F; Brusco A; Loffredo G; Rabbone I; Corrias A; Pignata C; Ramenghi U; Dianzani U
    Diabetes; 2001 Mar; 50(3):483-8. PubMed ID: 11246866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
    Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
    BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity.
    Martin DA; Combadiere B; Hornung F; Jiang D; McFarland H; Siegel R; Trageser C; Wang J; Zheng L; Lenardo MJ
    Novartis Found Symp; 1998; 215():73-82; discussion 82-91. PubMed ID: 9760572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human CD95 mutations on cell death and autoimmunity: a model.
    Seyrek K; Ivanisenko NV; Wohlfromm F; Espe J; Lavrik IN
    Trends Immunol; 2022 Jan; 43(1):22-40. PubMed ID: 34872845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
    Poppema S; Maggio E; van den Berg A
    Leuk Lymphoma; 2004 Mar; 45(3):423-31. PubMed ID: 15160902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
    Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
    Dianzani U; Bragardo M; DiFranco D; Alliaudi C; Scagni P; Buonfiglio D; Redoglia V; Bonissoni S; Correra A; Dianzani I; Ramenghi U
    Blood; 1997 Apr; 89(8):2871-9. PubMed ID: 9108407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome.
    Goldman FD; Vibhakar R; Puck JM; Straus SE; Ballas ZK; Hollenback C; Loew T; Thompson A; Song K; Cook RT
    Clin Immunol; 2002 Jul; 104(1):31-9. PubMed ID: 12139945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
    Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
    Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
    Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
    Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
    Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
    Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.